Medichem hosts European Commissioner for Health and Food Safety and Malta’s Deputy Prime Minister and Minister for Health at manufacturing sites.
Malta, 16 June 2023
European Commissioner for Health and Food Safety, Stella Kyriakides, along with Christopher Fearne, the Deputy Prime Minister and Minister for Health of Malta, visited the Medichem manufacturing sites as part of the Commissioner’s visit to Malta to speak at the Medicines for Europe Annual Conference. The conference has taken place from the 14th to the 16th of June 2023 and has been a platform for discussing policies and measures that will contribute to the improvement of patient health and the competitive pharmaceutical environment in Europe.
Medichem operates two sites in Malta (besides another two in Spain), one dedicated to the development and manufacture of active pharmaceutical ingredients (API), and the other to solid oral pharmaceutical products. The Maltese sites have been operational since 2005 and employ 150 professionals working in a variety of roles. The sites are involved in the development of new products as well as the commercial manufacture of a vibrant portfolio covering a broad spectrum of therapeutic areas, including oncologicals, anticoagulants, antifungals, and CNS medications. The facilities are EU GMP, US FDA, and most recently, ANVISA certified. The API site’s environmental care credentials are ISO 14001 certified.
“We are delighted to welcome Commissioner Kyriakides and Deputy Prime Minister and Minister Fearne to our facilities and to showcase our commitment towards the development of high-quality pharmaceuticals and continue investing in Europe,” said Elisabeth Stampa, Board Member of Medichem and President of Medicines for Europe. “Our aim is to produce affordable and innovative medicines that meet the highest quality standards, and our team of professionals is dedicated to that effort. We believe that it is important for officials such as Commissioner Kyriakides and Deputy Prime Minister Fearne to see first-hand how companies like ours contribute to the improvement of healthcare and supply security in Europe.”
Dino Mangion, Head of Operations at Medichem Malta, added: “It is an honour for us to host Commissioner Kyriakides and Minister Fearne. We are proud that our Maltese plants are certified by the most demanding Health authorities, and we are committed to maintaining these standards in order to provide quality products that meet the needs of patients worldwide. We are delighted to show our sites to Commissioner Kyriakides and Minister Fearne and to illustrate what we believe is important in the production of high-quality pharmaceuticals.”
Medichem’s commitment to investing in Europe has not gone unnoticed. The company has acquired a facility in Asturias to produce injectables, thus completing its production offer with parenteral solutions. Also, Medichem is currently expanding its Combino Pharm facilities to enlarge their portfolio and make medicines more accessible, affordable, and available.
The visit to the Medichem manufacturing sites was seen as a relevant step to explain and showcast the high quality and production requirements the production of APIs and FDFs require. The Medicines for Europe Annual Conference has provided an opportunity for further discussions and collaboration in the pharmaceutical industry with experts and policymakers in attendance.